Literature DB >> 31413131

LYAR Suppresses Beta Interferon Induction by Targeting Phosphorylated Interferon Regulatory Factor 3.

Cha Yang1, Xiaokun Liu1, Tailang Cheng1, Rong Xiao1, Qingxia Gao1, Fan Ming1, Meilin Jin1,2, Huanchun Chen1,2, Hongbo Zhou3,2.   

Abstract

The innate immune response is vital for host defense and must be tightly controlled, but the mechanisms responsible for its negative regulation are not fully understood. The cell growth-regulating nucleolar protein LYAR was found to promote replication of multiple viruses in our previous study. Here, we report that LYAR acts as a negative regulator of innate immune responses. We found that LYAR expression is induced by beta interferon (IFN-β) during virus infection. Further studies showed that LYAR interacts with phosphorylated IFN regulatory factor 3 (IRF3) to impede the DNA binding capacity of IRF3, thereby suppressing the transcription of IFN-β and downstream IFN-stimulated genes (ISGs). In addition, LYAR inhibits nuclear factor-κB (NF-κB)-mediated expression of proinflammatory cytokines. In summary, our study reveals the mechanism of LYAR in modulating IFN-β-mediated innate immune responses by targeting phosphorylated IRF3, which not only helps us to better understand the mechanisms of LYAR-regulated virus replication but also uncovers a novel role of LYAR in host innate immunity.IMPORTANCE Type I interferon (IFN-I) plays a critical role in the antiviral innate immune responses that protect the host against virus infection. The negative regulators of IFN-I are important not only for fine-tuning the antiviral responses to pathogens but also for preventing excessive inflammation. Identification of negative regulators and study of their modulation in innate immune responses will lead to new strategies for the control of both viral and inflammatory diseases. Here, we report for the first time that the cell growth-regulating nucleolar protein LYAR behaves as a repressor of host innate immune responses. We demonstrate that LYAR negatively regulates IFN-β-mediated immune responses by inhibiting the DNA binding ability of IFN regulatory factor 3 (IRF3). Our study reveals a common mechanism of LYAR in promoting different virus replication events and improves our knowledge of host negative regulation of innate immune responses.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  IFN-β; IRF3; LYAR; innate immune responses

Mesh:

Substances:

Year:  2019        PMID: 31413131      PMCID: PMC6803289          DOI: 10.1128/JVI.00769-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

Review 1.  IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors.

Authors:  Kenya Honda; Tadatsugu Taniguchi
Journal:  Nat Rev Immunol       Date:  2006-09       Impact factor: 53.106

2.  Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300.

Authors:  M Yoneyama; W Suhara; Y Fukuhara; M Fukuda; E Nishida; T Fujita
Journal:  EMBO J       Date:  1998-02-16       Impact factor: 11.598

3.  Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1.

Authors:  B K Weaver; K P Kumar; N C Reich
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

Review 4.  Putting the brakes on the anti-viral response: negative regulators of type I interferon (IFN) production.

Authors:  Kathryn H Richards; Andrew Macdonald
Journal:  Microbes Infect       Date:  2011-01-20       Impact factor: 2.700

5.  Upregulation of LYAR induces neuroblastoma cell proliferation and survival.

Authors:  Yuting Sun; Bernard Atmadibrata; Denise Yu; Matthew Wong; Bing Liu; Nicholas Ho; Dora Ling; Andrew E Tee; Jenny Wang; Imran N Mungrue; Pei Y Liu; Tao Liu
Journal:  Cell Death Differ       Date:  2017-07-07       Impact factor: 15.828

6.  Inducible TAP1 Negatively Regulates the Antiviral Innate Immune Response by Targeting the TAK1 Complex.

Authors:  Zhangchuan Xia; Gang Xu; Xiaodan Yang; Nanfang Peng; Qi Zuo; Shengli Zhu; Hua Hao; Shi Liu; Ying Zhu
Journal:  J Immunol       Date:  2017-03-29       Impact factor: 5.422

7.  Use of confocal immunofluorescence microscopy to localize viral nonstructural proteins and potential sites of replication in pigs experimentally infected with foot-and-mouth disease virus.

Authors:  P Monaghan; J Simpson; C Murphy; S Durand; M Quan; S Alexandersen
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

8.  A method for protein extraction from different subcellular fractions of laticifer latex in Hevea brasiliensis compatible with 2-DE and MS.

Authors:  Xuchu Wang; Minjing Shi; Xiuli Lu; Ruifeng Ma; Chenggong Wu; Anping Guo; Ming Peng; Weimin Tian
Journal:  Proteome Sci       Date:  2010-06-18       Impact factor: 2.480

9.  Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression.

Authors:  Christopher R Bolen; Siyuan Ding; Michael D Robek; Steven H Kleinstein
Journal:  Hepatology       Date:  2014-02-18       Impact factor: 17.425

Review 10.  Interferon-stimulated genes and their antiviral effector functions.

Authors:  John W Schoggins; Charles M Rice
Journal:  Curr Opin Virol       Date:  2011-12       Impact factor: 7.090

View more
  5 in total

1.  Elevated mRNA Level of Y-Box Binding Protein 1 Indicates Unfavorable Prognosis Correlated with Macrophage Infiltration and T Cell Exhaustion in Luminal Breast Cancer.

Authors:  Zhenhuan Lv; Chunli Xue; Lei Zhang; Jujie Sun; Cong Bo
Journal:  Cancer Manag Res       Date:  2021-08-14       Impact factor: 3.989

Review 2.  Of Keeping and Tipping the Balance: Host Regulation and Viral Modulation of IRF3-Dependent IFNB1 Expression.

Authors:  Hella Schwanke; Markus Stempel; Melanie M Brinkmann
Journal:  Viruses       Date:  2020-07-07       Impact factor: 5.048

3.  Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2.

Authors:  Matthias Thoms; Robert Buschauer; Michael Ameismeier; Lennart Koepke; Timo Denk; Maximilian Hirschenberger; Hanna Kratzat; Manuel Hayn; Timur Mackens-Kiani; Jingdong Cheng; Jan H Straub; Christina M Stürzel; Thomas Fröhlich; Otto Berninghausen; Thomas Becker; Frank Kirchhoff; Konstantin M J Sparrer; Roland Beckmann
Journal:  Science       Date:  2020-07-17       Impact factor: 47.728

4.  Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2.

Authors:  Na Chen; Baoge Zhang; Lulu Deng; Bing Liang; Jihui Ping
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 19.568

5.  LYAR Promotes Colorectal Cancer Progression by Upregulating FSCN1 Expression and Fatty Acid Metabolism.

Authors:  Yupeng Wu; Yu Zhou; Haiying Gao; Yajun Wang; Qingyu Cheng; Shikun Jian; Qi Ding; Wei Gu; Yanxue Yao; Jia Ma; Wenjuan Wu; Yuyun Li; Xuhui Tong; Xiaoyuan Song; Sai Ma
Journal:  Oxid Med Cell Longev       Date:  2021-12-06       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.